Keyphrases
Conditioning Regimen
100%
Acute Myeloid Leukemia
100%
Sequential Treatment
100%
Treosulfan
100%
FLAG-Ida
100%
Non-relapse Mortality
60%
Patient Selection
40%
Patient-completed
20%
Treatment Efficacy
20%
High Risk
20%
Mortality Rate
20%
Retrospective Analysis
20%
Leukemia Patients
20%
Remission
20%
Overall Survival
20%
Disease Burden
20%
Hematologic
20%
Disease-free Survival
20%
Idarubicin
20%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
Infectious Complications
20%
Reduced-intensity Conditioning
20%
Fludarabine
20%
Myeloablative Conditioning
20%
Median Overall Survival
20%
Salvage Chemotherapy
20%
Total Body Irradiation
20%
Donor chimerism
20%
Cytarabine
20%
Antileukemic Activity
20%
Comorbidity Scores
20%
Sequential Protocol
20%
Obstacles to Treatment
20%
Sequential Strategy
20%
Medicine and Dentistry
Conditioning
100%
Acute Myeloid Leukemia
100%
Treosulfan
100%
Overall Survival
40%
Mortality Rate
20%
Transplantation
20%
Hematopoietic Stem Cell
20%
Cell Transplantation
20%
Disease Burden
20%
Disease Free Survival
20%
Chimera
20%
Infectious Complication
20%
Cytarabine
20%
Reduced Intensity Conditioning
20%
Fludarabine
20%
Nonmyeloablative Conditioning
20%
Whole Body Radiation
20%
Idarubicin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Treosulfan
100%
Overall Survival
40%
Disease
20%
Comorbidity
20%
Chemotherapy
20%
Mortality Rate
20%
Remission
20%
Disease Free Survival
20%
Idarubicin
20%
Fludarabine
20%
Infectious Complication
20%
Cytarabine
20%